Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma. - Wikidata - awgldk - TriplyDB

Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.

Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.

http://www.wikidata.org/entity/Q34807396

about

SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis.SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17β-estradiol biosynthesis in endometrial carcinoma microenvironment.Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes.EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway.PCAF-mediated Akt1 acetylation enhances the proliferation of human glioblastoma cells.Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.The associations between common SNPs of EFEMP1 gene and glioma risk in Chinese population.The diagnostic role of DNA methylation in sporadic endometrial cancer: a systematic review and meta-analysis.Expression of tumor suppressor programmed cell death 4 in endometrioid endometrial carcinomas and clinicopathological significance.

P2860

Q33582882-ADBAA575-E425-4960-A577-2495EE9AA655 Q33740510-716FB3D9-0323-4FD2-AE27-936765D07A21 Q34485913-DDA6F3CA-8E63-46FF-8D74-7A1D9A01CE74 Q35069015-072A0555-82CA-482E-A35E-BFFD1D1F5A9D Q35882554-E2087474-B38A-4395-8CD9-2F489D04AFD9 Q35987298-625825AB-4D26-4E52-992B-7911A8205F48 Q36794310-E698A3B3-E8C3-4B22-9787-0608EB62F2B7 Q36985263-E56C438C-06C9-41E6-8363-87D17DEAE00B Q37295470-232E0273-A60E-48EC-95C1-3CC3EEA6B395 Q37717845-CD8C5F65-4579-4392-B69D-C074C0BFF8E3 Q37745906-461E5634-C92B-4C1F-A763-3BE2B80D7A41 Q38630962-E249643D-992D-430F-884F-0F91AC4C0E53 Q38652434-ACFE104C-F2EC-4BE4-B638-7408E9ECB9A5 Q38929285-BC7C8BD7-74C5-4869-9274-DC1883C13074 Q38957460-09DE3A13-8AD4-42EB-ABAF-C7B374444EAA Q39282288-4291DD06-3F6B-4D14-BFB2-3631A3E24FF4 Q46582256-13A54CE2-27DB-4CB0-ABFB-ECC900E8A1D0 Q50350380-60BEA76F-CC7C-4528-8352-1ED5531BD7C7 Q54968631-A0160779-6807-424E-BD03-AF6505F7825A

P2860

Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.

http://www.wikidata.org/entity/Q34807396

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@ast

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@en

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@nl

type

label

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@ast

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@en

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@nl

prefLabel

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@ast

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@en

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@nl

P1433

Q34807396-DCC44318-CEA5-4561-BD6D-C310B4A5320C

P1476

Q34807396-2690D8F2-8C66-4204-A96A-7CB3534957A0

P2093

Q34807396-1F774B3F-E25B-4883-A813-4655A46CCB73

Q34807396-4444EC49-F15B-4ABA-B2A1-1628738E3CE0

Q34807396-627180ED-B4E6-4012-B851-A193B1FF1B1B

Q34807396-6BF2DAE2-8467-48F6-AFCB-233ABCEB5AC6

Q34807396-6D76E857-FB23-4F5C-A6E7-B30D2C7C252B

Q34807396-B59E2787-2200-49A6-82B0-0654A570BB5C

Q34807396-BF43EBE9-BCD3-4F75-82F7-BD10A4E6DA46

Q34807396-D47752C2-0CD6-4AE4-BF23-AEA9B7C39C4B

Q34807396-FFF98BE1-85C0-4916-97B7-7D2B564CBFC7

P2860

Q34807396-01477C21-8F49-422F-9B41-64358F23EAFE

Q34807396-0148B3EB-867F-46ED-8E66-851FEC67B305

Q34807396-0D27DFA6-EE77-485F-A142-7AC564377389

Q34807396-10B81E80-AB12-4F4B-9AB8-22A90332F1D9

Q34807396-12A66EF9-D324-4E61-A735-24D19429E5B0

Q34807396-12E3D4F3-54B3-4BB2-A84B-A45316D7B2ED

Q34807396-1F3DA660-24B5-43D2-8D7F-2D1F3063FBA5

Q34807396-1F6B2C0B-D61A-438E-8D5D-B438B56F1180

Q34807396-2CA12008-25B0-48F0-B912-176E3F2E5414

Q34807396-34367650-FBE7-41BA-8196-EE0230824557

P304

Q34807396-C7E01461-AD42-4C00-8F35-FE4D3D103DF4

P31

Q34807396-EBB08270-3D0F-4DC3-806D-EA2218CE3921

P356

Q34807396-FA67E582-55DA-4F90-A0D3-837DCBF3F2E1

P407

Q34807396-F414BCA0-C2A0-4251-B8B5-961BBE7CA939

P433

Q34807396-3DE381A9-F9E8-4329-B818-42AD5D7C0A66

P478

Q34807396-8E655D91-5137-4F87-9D8C-61B38748A307

P577

Q34807396-82EA4AD6-7843-4981-82BE-4FD18675D020

P5875

Q34807396-4AE7249D-A2F3-4D9C-90FE-FDDFAD064D73

P698

Q34807396-4E433441-944C-42AC-B89B-79A188998A76

P932

Q34807396-EF72592E-4F34-4A36-8076-7E7C97015CE8

P356

JOURNAL.PONE.0067458

P1433

P1476

Epigenetic inactivation of EFE ...... tion in endometrial carcinoma.

@en

P2093

Bilan Li

http://www.w3.org/2001/XMLSchema#string

Cong Lu

http://www.w3.org/2001/XMLSchema#string

Guiqiang Du

http://www.w3.org/2001/XMLSchema#string

Haifeng Qiu

http://www.w3.org/2001/XMLSchema#string

Lihua Wang

http://www.w3.org/2001/XMLSchema#string

Tingting Yang

http://www.w3.org/2001/XMLSchema#string

Wei Bao

http://www.w3.org/2001/XMLSchema#string

Xiaoping Wan

http://www.w3.org/2001/XMLSchema#string

Xin Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT)

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Cancer statistics, 2013

Fibulins: a versatile family of extracellular matrix proteins

Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation

Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations

Genome-wide association analysis identifies 20 loci that influence adult height

Cancer epigenetics: from mechanism to therapy

The history of cancer epigenetics

P304

e67458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0067458

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248385791

http://www.w3.org/2001/XMLSchema#string

P698

23840707

http://www.w3.org/2001/XMLSchema#string

P932

3696089

http://www.w3.org/2001/XMLSchema#string